In vitro susceptibility, clinical efficacy, and dose of current antibiotics for actinomycetoma and antifungal agents against M. mycetomatis.

Possible drug interactions, history of drug allergies, and co-morbidities should be analyzed in all drugs.IM, intramuscularly; IV, intravenous; PO, orally; tid, three times daily.In vitro susceptibility, clinical efficacy, and dose of current antibiotics for actinomycetoma and antifungal agents against M. mycetomatis.

所有药物均需分析潜在药物相互作用、药物过敏史及合并症。
缩写说明：IM代表肌内注射（intramuscularly），IV代表静脉注射（intravenous），PO代表口服（orally），tid代表每日三次（three times daily）。
本数据集涵盖当前用于足菌肿（actinomycetoma）的抗生素以及抗M. mycetomatis的抗真菌药物的体外敏感性、临床疗效与给药剂量。